Ensuring Access to Clinical Trials Act of 2015 became law 272 days after introduction, with cosponsors from both parties
IntroducedJan 8, 2015
Reported—
Passed one chamberJul 16, 2015
Passed bothSep 28, 2015
LawOct 7, 2015
What it changes · CRS summary
Written by the Congressional Research Service [2]. 96 words.
This measure has not been amended since it was introduced. The expanded summary of the Senate-passed version is repeated here.) Ensuring Access to Clinical Trials Act of 2015
(Sec. 2) This bill amends the Improving Access to Clinical Trials Act of 2009 to repeal the sunset of, and so extend indefinitely, the exclusion from resources under titles XVI (Supplemental Security Income) and XIX (Medicaid) of the Social Security Act, for eligibility purposes, of compensation in the amount of the first $2,000 per year received by individuals who participate in clinical trials for rare diseases or conditions.
Context
- Committees
- House Energy and Commerce Committee
House Ways and Means Committee
Senate Finance Committee - Policy area
- Health: 122 of 9,357 bills became law, 113th–118th (1.3%)
- Sponsor
- 7 of 533 bills enacted since 2013
- Text versions
- 5, from enrolled bill to public law · 277 words
- Subjects
- MedicaidMedical researchPoverty and welfare assistance
- Latest action
- Oct 7, 2015: Became Public Law No: 114-63.
- Records
- Congress.gov · Bill text
Exhibit 1Passage odds band at each stage, rated when the bill reached it [4]
Related bills · 1
Each bill appears once, under its strongest link. 1 in all.
Identical or companion · 1
- 114th H.R. 209 Ensuring Access to Clinical Trials Act of 2015 D · Introduced
Exhibit 2Articles naming the bill per day, last 90 days, US sources [3]